Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
- Status
- TERMINATED
- Phase
- PHASE2
RNA-Loaded Dendritic Cell Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of CP-461 in Patients With Advanced Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
BMS 247550 to Treat Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
- Status
- COMPLETED
- Phase
- N/A
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
- Status
- UNKNOWN
- Phase
- PHASE1
Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- Status
- RECRUITING
- Phase
- N/A